These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6752032)

  • 1. Type-specific protection of neonatal rats from lethal group B streptococcal infection by immune sera obtained from human volunteers vaccinated with type III-specific polysaccharide.
    De Cueninck BJ; Eisenstein TK; McIntosh TS; Shockman GD; Swenson RM
    Infect Immun; 1982 Sep; 37(3):961-5. PubMed ID: 6752032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse protection assay for group B streptococcus type III.
    Fleming DO
    Infect Immun; 1982 Jan; 35(1):240-7. PubMed ID: 6172381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group B streptococcal vaccines.
    Baker CJ; Kasper DL
    Rev Infect Dis; 1985; 7(4):458-67. PubMed ID: 3898306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.
    Paoletti LC; Wessels MR; Rodewald AK; Shroff AA; Jennings HJ; Kasper DL
    Infect Immun; 1994 Aug; 62(8):3236-43. PubMed ID: 8039893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.
    Baker CJ; Rench MA; Edwards MS; Carpenter RJ; Hays BM; Kasper DL
    N Engl J Med; 1988 Nov; 319(18):1180-5. PubMed ID: 3050524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination in human sera of vaccine-induced antibody to type-specific polysaccharides of group B streptococci using an enzyme-linked immunosorbent assay.
    Eisenstein TK; De Cueninck BJ; Resavy D; Shockman GD; Carey RB; Swenson RM
    J Infect Dis; 1983 May; 147(5):847-56. PubMed ID: 6341484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the protective level of human IgG antibody to the type-specific polysaccharide of group B Streptococcus type Ia.
    Klegerman ME; Boyer KM; Papierniak CK; Gotoff SP
    J Infect Dis; 1983 Oct; 148(4):648-55. PubMed ID: 6355310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.
    Wessels MR; Paoletti LC; Kasper DL; DiFabio JL; Michon F; Holme K; Jennings HJ
    J Clin Invest; 1990 Nov; 86(5):1428-33. PubMed ID: 2243123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.
    Wessels MR; Paoletti LC; Rodewald AK; Michon F; DiFabio J; Jennings HJ; Kasper DL
    Infect Immun; 1993 Nov; 61(11):4760-6. PubMed ID: 8406875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults.
    Kotloff KL; Fattom A; Basham L; Hawwari A; Harkonen S; Edelman R
    Vaccine; 1996 Apr; 14(5):446-50. PubMed ID: 8735558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.
    Gravekamp C; Kasper DL; Paoletti LC; Madoff LC
    Infect Immun; 1999 May; 67(5):2491-6. PubMed ID: 10225912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monoclonal antibodies to group B streptococcus. Reactivity and in vivo protection against multiple serotypes.
    Raff HV; Siscoe PJ; Wolff EA; Maloney G; Shuford W
    J Exp Med; 1988 Sep; 168(3):905-17. PubMed ID: 3049909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
    J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assay.
    Edwards MS; Fuselier PA; Rench MA; Kasper DL; Baker CJ
    Infect Immun; 1984 May; 44(2):257-61. PubMed ID: 6370863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective levels of human immunoglobulin G antibody to group B streptococcus type Ib.
    Boyer KM; Kendall LS; Papierniak CK; Klegerman ME; Gotoff SP
    Infect Immun; 1984 Sep; 45(3):618-24. PubMed ID: 6381309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4.
    Musher DM; Johnson B; Watson DA
    Infect Immun; 1990 Dec; 58(12):3871-6. PubMed ID: 2254015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.
    Madoff LC; Paoletti LC; Tai JY; Kasper DL
    J Clin Invest; 1994 Jul; 94(1):286-92. PubMed ID: 7518832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity and protective activity of murine monoclonal antibodies directed against the capsular polysaccharide of type III group B streptococci.
    Teti G; Calapai M; Calogero G; Tomasello F; Mancuso G; Galli A; Riggio G
    Hybridoma; 1992 Feb; 11(1):13-22. PubMed ID: 1371105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of antibodies to type III group B streptococcal polysaccharide.
    Guttormsen HK; Baker CJ; Edwards MS; Paoletti LC; Kasper DL
    J Infect Dis; 1996 Jan; 173(1):142-50. PubMed ID: 8537651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine.
    Marques MB; Kasper DL; Shroff A; Michon F; Jennings HJ; Wessels MR
    Infect Immun; 1994 May; 62(5):1593-9. PubMed ID: 8168919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.